During the past decade, Solihull Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Solihull Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Solihull Hospital" are "Estrogen Receptor Positive Breast Cancer" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Solihull Hospital" in a lesser frequency.

Most popular intervention types in "Solihull Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AZD2014" (1 trials), "DMARDs" (1 trials), "Everolimus" (1 trials), "Fulvestrant" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Solihull Hospital" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Solihull Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Solihull Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Solihull Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".